TMパートナーズ合同会社

Multifunctional support for businesses in the healthcare field

Over 30 years of multifaceted experience in R&D, operations, management, and human resource development of pharmaceuticals and medical devices in various Japanese and international organizations (academia, business companies, investment companies, and local governments)

Experienced in academia drug discovery research and licensing that resulted patents in the U.S.
Experienced in drug discovery research, launching a new business, and business development within a pharmaceutical company
Hands-on investment in listed Japanese biotech companies
Invested in Japanese and European biotech ventures as a venture capitalist
Participation in corporate management as an External Director and Chair of Audit and Supervisory Committee

Past Projects

Providing a variety of services tailored to client needs

Advice on critical issues facing business functions

Advice on general business operations
Advice on research and development activities
Support for commercialization of technologies and drug discovery in academia

Advice on business development

Support for business development and licensing
Advice on business alliances and M&A schemes

Advice on investment projects

Evaluation of new investment opportunities
Due diligence of new investment opportunities
Advice on existing portfolio companies

Human resource development

Counseling for CEOs
Training for human resource development (Japanese and English)
- Training for global leaders and leadership training for the new era
- New business creation and value maximization

Overview

Message from the CEO

The operational rationale of TM Partners:
I would like to reflect on what I value in my work. As a student, I was trained in the fundamentals of research by a professor who was passionate about education. In my third year of the doctoral program, I was exposed to drug discovery research as an intern at a U.S. research institute of a global pharmaceutical company. After obtaining a Ph.D. in Pharmaceutical Sciences, I spent 11 years as a member of the U.S. National Cancer Institute, where I experienced the excitement and rigors of research and development in an intensely competitive environment. During this time, I experienced drug discovery in academia, successfully out-licensed two biopharmaceutical candidates of which I was involved in the research and development, and learned American-style management and human resource development.

I then joined a Japanese pharmaceutical company, where I gained valuable business experience not only as a research leader in antibody drugs, but also in launching new businesses in the U.S., exploring and evaluating new external technologies and pipelines, and in business development. After that, I had the opportunity to move to an investment company that made hands-on investments in listed Japanese biotech companies, where I came to various realizations. I founded TM Partners LLC with the desire to assist in the research and development of academia drug discovery and venture companies in Japan, as well as in the management and human resource development of the new era.

My creed is to “save as many patients as possible as soon as possible” when accepting professional challenges. From an objective standpoint, I consider whether the client's research and development is truly being conducted in the most optimal manner, whether the organization is being managed appropriately. TM Partners is committed to helping realize an affluent society with wellbeing by providing “multifunctional support for businesses in the healthcare field.”

October 1, 2024
Toshiyuki Mori

Company Name	TM Partners LLC
CEO	Toshiyuki Mori, Ph.D.
Year of establishment	2018

Biography

1990

Passed the national pharmacist exam
1992 ~
1995

Research Fellowship for Young Scientists, Japan Society for the Promotion of Science
1995

Intern, Hoffman La Roche (NJ, USA)
1995

Completed doctoral course at Hokkaido University Graduate School of Pharmaceutical Sciences and obtained a Ph.D. in Pharmaceutical Sciences.
1995 ~
2005

Worked primarily in biopharmaceutical and infectious disease research at the U.S. National Cancer Institute for 11 years. Two substances, including one discovered by myself, have entered clinical trials with clinical trials still ongoing.
2005 ~
2014

At Takeda Pharmaceutical Company Limited, while leading the team for pharmacological evaluation of antibody drugs, I was involved in the business strategy of antibody drug R&D. I was also in charge of directing the launch of the antibody research institute in the U.S., conducting external technology evaluations of all disease areas and platform technologies, contract negotiations/conclusion and alliance management. In addition, participating in multiple company-wide projects on behalf of the department.
2014 ~
2018

Joined an independent investment firm which invested in and provided direct support to biotech venture companies listed in Japan, and also helped commercialize the research results of multiple academic institutions.
2018 ~

Founded TM Partners, LLC, which provides consulting services to academia, biotech companies, venture capitals, and business corporations. I have also been involved in human resource development training for major pharmaceutical companies and counseling for CEOs. As part of business, I became an investment partner of a European venture capital firm for two years from October 2018, investing in unlisted companies in Japan and Europe in the areas of drug discovery and medical devices.

Peer review papers: 45; Patents granted in the United States: 5

Current main position

2019 ~

External Director, Edit Force, Inc.
2019 ~

Evaluation Committee Member, Japan Agency for Medical Research and Development (AMED)
2020 ~

Deputy Director, Toyama Pharmaceutical Vally Development Consortium, Toyama Prefecture Gov.
2020 ~

External Director and Chair of Audit and Supervisory Committee, J-Pharma Co., Ltd.
2022 ~

Startup Strategy Committee Member, Toyama Prefecture Gov.
2023 ~

Expert Committee Member, JST “University-originated new industry creation fund project feasibility verification”

Contact

Personal information obtained from inquiries will be used only to the extent necessary for responding to inquiries, and will be handled strictly in accordance with the privacy policy.
Please refrain from inquiries involving solicitations/sales purposes.

※ is Required fields.

Name※
Affiliation※
Email address※
Phone number※
Introducer's name※
Introducer’s affiliation※
Inquiry details※

Privacy Policy

TM Partners LLC (hereinafter referred to as "Company") has established the following privacy policy (hereinafter referred to as "this policy") regarding the handling of personal information of users when they use the "Contact Us" function of this website.

Article 1 (Personal Information)

"Personal information" refers to "personal information" as defined in the Personal Information Protection Act, which is information about a living individual that can identify a specific individual based on the name, date of birth, address, telephone number, contact information, and other descriptions contained in the information, as well as data related to appearance, fingerprints, voiceprints, and information that can identify a specific individual from the information alone, such as the insurer number on a health insurance card (personal identification information).

Article 2 (Method of collecting personal information)

When users use the "Contact Us" function of this website, we ask for personal information such as name, affiliation, email address, phone number, introducer's name, introducer’s affiliation, and inquiry details.

Article 3 (Purpose of collecting and using personal information)

To respond to "inquiries" (including identity verification)
To send emails informing users of the services we provide
To contact users as necessary, such as for maintenance and important notices
To identify users who have violated the terms of use or who are attempting to use the service for fraudulent or unjust purposes, and to refuse their use
Purposes incidental to the above purposes of use

Article 4 (Changes in purpose of use)

The Company will change the purpose of use of personal information only if it is reasonably deemed that the new purpose of use is related to the previous purpose.
If the purpose of use is changed, we will notify users of the new purpose in a manner specified by our company or publish it on this website.

Article 5 (Provision of personal information to third parties)

We will not provide personal information to third parties without the prior consent of the user, except in the following cases. However, this does not apply to cases permitted by the Japan Personal Information Protection Act or other laws and regulations.
1. When it is necessary for the protection of a person's life, body, or property, and it is difficult to obtain the consent of the individual
2. When it is particularly necessary for the improvement of public health or the promotion of healthy child development, and it is difficult to obtain the consent of the individual
3. When it is necessary to cooperate with a national institution, local government, or a person commissioned by them to carry out duties prescribed by law, and obtaining the consent of the individual may hinder the performance of such duties
4. When the following matters have been notified or announced in advance and the Company has notified the Personal Information Protection Commission
  1. The purpose of use includes provision to a third party
  2. Items of data provided to a third party
  3. Means or method of provision to a third party
  4. To stop providing personal information to a third party at the request of the individual
  5. Method of accepting the request of the individual
Notwithstanding the provisions of the preceding paragraph, in the following cases, the recipient of the information will not be a third party.
1. When the Company entrusts all or part of the handling of personal information to a third party within the scope necessary to achieve the purpose of use.
2. When personal information is provided as a result of business succession due to a merger or other reason.
3. When personal information is used jointly with a specific person, the individual is notified in advance or made easily accessible to the individual of the fact, the items of personal information to be used jointly, the scope of the parties using the personal information jointly, the purpose of use by the parties using the personal information, and the name or title of the person responsible for managing the personal information.

Article 6 (Disclosure of Personal Information)

When the individual requests disclosure of personal information, we will disclose it to the individual without delay. However, if disclosure would fall under any of the following, we may not disclose all or part of the information, and if we decide not to disclose it, we will notify you of this without delay.
1. If there is a risk of harm to the life, body, property, or other rights and interests of the individual or a third party
2. If there is a risk of significant interference with the proper implementation of our business
3. If there is a violation of other laws and regulations
Notwithstanding the provisions of the preceding paragraph, in principle, we will not disclose information other than personal information, such as history information and characteristic information.

Article 7 (Correction and Deletion of Personal Information)

If the personal information held by the Company is incorrect, the User may request the Company to correct, add, or delete the personal information (hereinafter referred to as "Correction, etc.") in accordance with the procedures stipulated by the Company.
If the Company receives a request from the User as described in the preceding paragraph and determines that it is necessary to comply with the request, the Company shall correct the personal information without delay.
If the Company makes a correction, etc. based on the provisions of the preceding paragraph, or decides not to make a correction, etc., the Company shall notify the User without delay.

Article 8 (Suspension of Use of Personal Information, etc.)

If the User requests the Company to suspend or delete the use of the personal information (hereinafter referred to as "Suspension of Use, etc.") on the grounds that the personal information is being handled beyond the scope of the purpose of use or has been obtained by illegal means, the Company shall conduct the necessary investigation without delay.
If the Company determines that it is necessary to comply with the request based on the results of the investigation in the preceding paragraph, the Company shall suspend the use of the personal information without delay.
When the Company suspends or otherwise decides not to suspend or otherwise suspend use pursuant to the provisions of the preceding paragraph, the Company will notify the User without delay.
Notwithstanding the preceding two paragraphs, if suspending or otherwise suspending use would involve significant expenses or is otherwise difficult, and alternative measures necessary to protect the User's rights and interests can be taken, the Company will take these alternative measures.

Article 9 (Changes to Privacy Policy)

The contents of this policy may be changed without notifying users, except as otherwise provided by law or other provisions of this policy.
Unless otherwise specified by the Company, the changed privacy policy will take effect from the time it is posted on this website.

Article 10 (Contact Information)

For inquiries regarding this policy, please contact the "Contact Information" on this website.

If you agree to the privacy policy, please check the box below.

I agree to the privacy policy